Credit Suisse’s HUMANIGEN, INC. HGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-26
Closed 4446
2022
Q2
$0 Sell
26
-24,507
-100% -$55K ﹤0.01% 4513
2022
Q1
$73K Buy
24,533
+2,148
+10% +$5.75K ﹤0.01% 3495
2021
Q4
$84K Buy
22,385
+3,335
+18% +$19.5K ﹤0.01% 4398
2021
Q3
$112K Buy
19,050
+2,240
+13% +$31.5K ﹤0.01% 4310
2021
Q2
$292K Buy
16,810
+4,047
+32% +$73.8K ﹤0.01% 4126
2021
Q1
$244K Buy
+12,763
New +$233K ﹤0.01% 4067

Other funds holding HGEN

Credit Suisse's HGEN Position: Q3 2022 in Review

Credit Suisse sold out of HUMANIGEN, INC. (HGEN) in Q3 2022, closing a stake of 26 shares.

Credit Suisse first reported a position in HGEN in Q1 2021 and held it in 6 quarters. The position peaked at $292K in Q2 2021. 53 funds tracked by Wall St. Rank hold HGEN as of Q3 2022.

  • Credit Suisse reported no remaining HUMANIGEN, INC. position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 26 HUMANIGEN, INC. shares in Q3 2022.
  • Credit Suisse first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 6 quarters.
  • Credit Suisse's HUMANIGEN, INC. position peaked at $292K in Q2 2021.
  • 53 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.